Company Profiles

driven by the PitchBook Platform

GeneCentric Diagnostics

Description

Developer of molecular diagnostic tests for oncologists and patients. The company engages in developing tests that identifies patients who would benefit from drugs that inhibit tumor growth. It's technology, Cancer Subtype Platform (CSP), identifies sub-types through an integrated analysis of tumor genomics, which leads to to rational clinical trial design, accurate prediction of drug response, efficient target selection in drug development and improved treatment outcomes.

2011

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$6.11M

Latest Deal Amount

$11.4M

Total Amount Raised

Description

Developer of molecular diagnostic tests for oncologists and patients. The company engages in developing tests that identifies patients who would benefit from drugs that inhibit tumor growth. It's technology, Cancer Subtype Platform (CSP), identifies sub-types through an integrated analysis of tumor genomics, which leads to to rational clinical trial design, accurate prediction of drug response, efficient target selection in drug development and improved treatment outcomes.

Website:

www.genecentric.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

280 South Mangum Street Suite 350 Durham, NC 27701United States +1 (919) 973-6544
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore GeneCentric Diagnostics's full profile, request a free trial.

    GeneCentric Diagnostics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    GeneCentric Diagnostics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    GeneCentric Diagnostics Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Hatteras Venture PartnersVenture CapitalMinority000 0000000 0000
    LabCorp VenturesOtherMinority000 0000000 0000
    Hatteras Venture Partners Venture Capital
    LabCorp Ventures Other

    GeneCentric Diagnostics Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Hawazin Faruki Ph.DChief Scientific Officer
    Christy FergusonVice President, Business Development
    Myla Lai-Goldman MDCo-Founder, Chief Executive Officer, President & Board Member
    Hawazin Faruki Ph.D Chief Scientific Officer
    Christy Ferguson Vice President, Business Development
    Myla Lai-Goldman MD Co-Founder, Chief Executive Officer, President & Board Member

    GeneCentric Diagnostics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Arnold Levine Ph.DHatteras Venture PartnersScientific Advisor000 0000
    Charles Perou Ph.DGeneCentric DiagnosticsCo-Founder & Board Member000 0000
    Clay ThorpHatteras Venture PartnersCo-Founder & General Partner000 0000
    David Hayes MDSelfCo-Founder & Board Member000 0000
    Myla Lai-Goldman MDSelfCo-Founder, Chief Executive Officer, President & Board Member000 0000
    Arnold Levine Ph.D Scientific Advisor Hatteras Venture Partners
    Charles Perou Ph.D Co-Founder & Board Member GeneCentric Diagnostics
    Clay Thorp Co-Founder & General Partner Hatteras Venture Partners
    David Hayes MD Co-Founder & Board Member Self
    Myla Lai-Goldman MD Co-Founder, Chief Executive Officer, President & Board Member Self
    Request full access to PitchBook